Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT05058950
Other study ID # 285PI401
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date September 20, 2021
Est. completion date September 19, 2023

Study information

Verified date September 2023
Source Biogen
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The primary objectives are to develop and validate a classifier using multimodal passive sensor data and metrics derived from normal iPhone and Apple Watch usage to distinguish individuals with normal cognition from those with mild cognitive impairment (MCI) and to develop and validate a cognitive wellness score that tracks fluctuations in cognitive performance over time using multimodal passive sensor data and metrics derived from normal iPhone and Apple Watch usage.


Recruitment information / eligibility

Status Terminated
Enrollment 22720
Est. completion date September 19, 2023
Est. primary completion date September 19, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 86 Years
Eligibility Key Inclusion Criteria: - Fluent in spoken and written English - Minimum 8 years of education or 8th grade equivalent. - Willing to authorize the use of confidential health information in accordance with applicable privacy regulations. - Willing to wear an Apple Watch for daily use for the duration of the study. - Willing to use their personal iPhone for routine daily use for the duration of the study. - Technical requirements: iPhone models: iPhone 8 or newer iOS versions: current publicly available iOS version - Access to one of the following personal computing devices. Microsoft Windows based personal computers (laptops and desktops) Mac personal computers (laptops and desktops) Apple iPad tablets - Access to WiFi or hardwired internet access in participant's place of residence. - Active email address for enrollment account creation and for use in relaying study information. - Active mobile telephone number for use in relaying study information when appropriate. - Primary address within the United States (50 states and Washington, DC; not a post office (PO) box). Key Exclusion Criteria: - Inability to comply with study requirements. - Any self-reported medical history of dementia (such as Alzheimer's disease, frontotemporal dementia, dementia with Lewy body, vascular dementia, rapidly progressive dementia, or Parkinson's disease dementia). - Self-reported dependence on others to perform core activities of daily living, including feeding, dressing, bathing, toileting, or grooming. NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.

Study Design


Locations

Country Name City State
United States Virtual App-Based Study Cambridge Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Biogen Apple Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sensitivity and Specificity of the Classifier in Distinguishing Between Individuals With and Without MCI A classifier is a mathematical function that uses collected data to calculate the probability that an individual belongs in a given category. The reference standard for the classifier is clinical diagnosis of MCI in normal clinical care or in a research cohort. Up to Month 23
Primary Correlation Between the Cognitive Wellness Score and the Neuropsychological Testing Battery Score To develop and validate a cognitive wellness score that tracks fluctuations in cognitive performance over time using multimodal passive sensor data and metrics derived from normal iPhone and Apple Watch usage. Up to Month 23
Secondary Sensitivity and Specificity of the Classifier in Predicting Between Individuals Who Do and Do Not Develop MCI A classifier is a mathematical function that uses collected data to calculate the probability that an individual belongs in a given category. The reference standard for the classifier is clinical diagnosis of MCI in normal clinical care or in a research cohort. Up to Month 23
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A